Terns Pharmaceuticals to Join June Investor Conferences

Foster City, Calif., May 30, 2024 - Terns Pharmaceuticals (Nasdaq: TERN), a clinical-stage biopharmaceutical company focused on creating small molecule treatments for serious conditions, including cancer and obesity, has announced its participation in several significant investor conferences this June. The senior management team will be actively involved in these events, presenting the company’s recent progress and strategic direction.

Jefferies Global Healthcare Conference
- Format: Fireside Chat
- Date and Time: Wednesday, June 5, 2024, at 5:00 p.m. ET
- Location: Marriott Marquis, New York City

Goldman Sachs 45th Annual Global Healthcare Conference
- Format: Fireside Chat
- Date and Time: Tuesday, June 11, 2024, at 3:20 p.m. ET
- Location: Loews Miami Beach Hotel, Miami

These fireside chats will be live-streamed and accessible through the investor relations page on the Terns Pharmaceuticals website. For those unable to attend the live sessions, replays will be archived on the website for a minimum of 30 days post-event.

About Terns Pharmaceuticals
Terns Pharmaceuticals is dedicated to developing a wide range of small molecule therapies aimed at addressing critical health issues such as cancer and obesity. The company's current pipeline includes three programs in clinical development: an allosteric BCR-ABL inhibitor, a GLP-1 receptor agonist, and a THR-β agonist. Additionally, the company is advancing a preclinical program focused on a GIPR modulator, prioritizing the nomination of a GIPR antagonist candidate.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!